Production of Cannabis and Related Materials for Research
Closed Pre-Solicitation Posted
This opportunity was awarded. See the award notice from , or the latest solicitation from .
- Solicitation number
- 75N95022R00058
- Agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
Notice details come from SAM.gov. Updated .
About this opportunity
This pre-solicitation notice seeks proposals for a potential five-year IDIQ contract to produce cannabis and related materials for research by the National Institute on Drug Abuse. Mandatory requirements for offerors include possessing DEA registrations for Schedule I substances, secure indoor or outdoor growing facilities capable of 2,000 kg of marijuana annually, and extraction facilities for 500 kg of marijuana products. Offerors must also have laboratories for cannabis extraction, analysis, and production of cannabinoid extracts and non-GMP cannabinoids. The anticipated RFP response deadline will be approximately 45 days after its July 28, 2022 posting on SAM.gov.
There is no set-aside designated for this procurement. The main NAICS code is 325411 for medicinal and botanical manufacturing, with the primary PSC code for drug compounds. The current contractor is the University of Mississippi, though the anticipated award would replace their 2015 contract. Key details include provision of cGMP and placebo cannabis, cannabinoid extracts, and non-GMP cannabinoids in task orders over five years for NIDA's cannabis and cannabinoid research program.
Notice text
The purpose of this pre-solicitation notice is to notify potential offerors that the National Institute on Drug Abuse (NIDA) intends to solicit proposals for Production of Cannabis and Related Materials for Research from qualified contractors having the capability to perform the tasks identified in this pre-solicitation notice.
Mandatory criteria:
The below mandatory criteria establish conditions that must be met to be considered for this project.
1. In accordance with the Controlled Substances Act of 1970, any offerors must possess or demonstrate the capability to obtain Drug Enforcement Agency (DEA) Registrations for manufacture and distribution of Schedule I controlled substances including cannabis and its active and non-active constituents.
2. Offerors must demonstrate availability of secure indoor and/or outdoor growing facilities necessary to support production of up to 2000 kg of marijuana, in a given year, as well as extraction/purification capabilities necessary to produce up to 500 kg of marijuana products in a given year.
3. Offerors must demonstrate availability of laboratory facilities sufficient to perform extractions and analysis of cannabis and related materials.
4. Offerors must demonstrate availability of laboratory facilities to perform extractions of cannabis and production of cannabis related materials products.
Please see the attached 75N95022R00058 presolicitation notice for more details.
Files
| File | Type | Posted |
|---|---|---|
| 75N95022R00058_PreSol_Notice.pdf |
Notice history
| Notice | Type | Posted |
|---|---|---|
| Production of Cannabis and Related Materials for Research | Award Notice | |
| Production of Cannabis and Related Materials for Research | Solicitation | |
| This notice | Pre-Solicitation | |
| Production of Cannabis and Related Materials for Research | Pre-Solicitation |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Synthesis and Distribution of Drugs of Abuse and Related Compounds | National Institute on Drug Abuse | Total Small Business | |
| Synthesis and Distribution of Drugs of Abuse and Related Compounds | National Institute on Drug Abuse | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity